Heart failure after myocardial infarction: incidence and predictors

被引:373
作者
Jenca, Dominik [1 ,2 ]
Melenovsky, Vojtech [1 ]
Stehlik, Josef [3 ]
Stanek, Vladimir [1 ]
Kettner, Jiri [1 ]
Kautzner, Josef [1 ,4 ]
Adamkova, Vera [5 ]
Wohlfahrt, Peter [2 ,3 ,5 ,6 ,7 ]
机构
[1] Inst Clin & Expt Med, Dept Cardiol, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 3, Prague, Czech Republic
[3] Univ Utah, Sch Med, Div Cardiovasc Med, Salt Lake City, UT USA
[4] Palacky Univ, Fac Med, Dent, Olomouc, Czech Republic
[5] Inst Clin & Expt Med, Dept Prevent Cardiol, Prague, Czech Republic
[6] Charles Univ Prague, Ctr Cardiovasc Prevent, Fac Med 1, Videnska 800, Prague 14059 4, Czech Republic
[7] Charles Univ Prague, Thomayer Hosp, Videnska 800, Prague 14059 4, Czech Republic
关键词
Heart failure; Clinical risk factors; Biomarkers; Genetics; Adverse remodelling; LEFT-VENTRICULAR DYSFUNCTION; PERCUTANEOUS CORONARY INTERVENTION; CHRONIC KIDNEY-DISEASE; C-REACTIVE PROTEIN; BRAIN NATRIURETIC PEPTIDE; ST-ELEVATION; TROPONIN-T; EJECTION FRACTION; NATIONAL REGISTRY; DIABETES-MELLITUS;
D O I
10.1002/ehf2.13144
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The aim of the present paper was to provide an up-to-date view on epidemiology and risk factors of heart failure (HF) development after myocardial infarction. Methods and results Based on literature review, several clinical risk factors and biochemical, genetic, and imaging biomarkers were identified to predict the risk of HF development after myocardial infarction. Conclusions Heart failure is still a frequent complication of myocardial infarction. Timely identification of subjects at risk for HF development using a multimodality approach, and early initiation of guideline-directed HF therapy in these patients, can decrease the HF burden.
引用
收藏
页码:222 / 237
页数:16
相关论文
共 150 条
[1]   Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial [J].
Abraham, William T. ;
Adamson, Philip B. ;
Bourge, Robert C. ;
Aaron, Mark F. ;
Costanzo, Maria Rosa ;
Stevenson, Lynne W. ;
Strickland, Warren ;
Neelagaru, Suresh ;
Raval, Nirav ;
Krueger, Steven ;
Weiner, Stanislav ;
Shavelle, David ;
Jeffries, Bradley ;
Yadav, Jay S. .
LANCET, 2011, 377 (9766) :658-666
[2]   Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial [J].
Adamopoulos, Chris ;
Ahmed, Ali ;
Fay, Renaud ;
Angioi, Michael ;
Filippatos, Gerasimos ;
Vincent, John ;
Pitt, Bertram ;
Zannad, Faiez .
EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (11) :1099-1105
[3]   Prevalence and Predictive Value of Microvascular Flow Abnormalities after Successful Contemporary Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction [J].
Aggarwal, Sourabh ;
Xie, Feng ;
High, Robin ;
Pavlides, Gregory ;
Porter, Thomas R. .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2018, 31 (06) :674-682
[4]   Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction - The VALsartan In Acute myocardial iNfarcTion (VALIANT) trial [J].
Aguilar, D ;
Solomon, SD ;
Kober, L ;
Rouleau, JL ;
Skali, H ;
McMurray, JJV ;
Francis, GS ;
Henis, M ;
O'Connor, CM ;
Diaz, R ;
Belenkov, YN ;
Varshavsky, S ;
Leimberger, JD ;
Velazquez, EJ ;
Califf, RM ;
Pfeffer, MA .
CIRCULATION, 2004, 110 (12) :1572-1578
[5]   Predictive value of high sensitivity C-reactive protein on progression to heart failure occurring after the first myocardial infarction [J].
Al Aseri, Zohair A. ;
Habib, Syed Shahid ;
Marzouk, Ameer .
VASCULAR HEALTH AND RISK MANAGEMENT, 2019, 15 :221-227
[6]   Clinical predictors of heart failure in patients with first acute myocardial infarction [J].
Ali, AS ;
Rybicki, BA ;
Alam, M ;
Wulbrecht, N ;
Richer-Cornish, K ;
Khaja, F ;
Sabbah, HN ;
Goldstein, S .
AMERICAN HEART JOURNAL, 1999, 138 (06) :1133-1139
[7]   Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO study) [J].
Anavekar, Nagesh S. ;
Skali, Hicham ;
Bourgoun, Mikhail ;
Ghali, Jalal K. ;
Kober, Lars ;
Maggioni, Aldo P. ;
McMurray, John J. V. ;
Velazquez, Eric ;
Califf, Robert ;
Pfeffer, Marc A. ;
Solomon, Scott D. .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (05) :607-612
[8]  
[Anonymous], 1998, Circulation, V97, P2202
[9]   Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction The ARIC Community Surveillance Study [J].
Arora, Sameer ;
Stouffer, George A. ;
Kucharska-Newton, Anna M. ;
Qamar, Arman ;
Vaduganathan, Muthiah ;
Pandey, Ambarish ;
Porterfield, Deborah ;
Blankstein, Ron ;
Rosamond, Wayne D. ;
Bhatt, Deepak L. ;
Caughey, Melissa C. .
CIRCULATION, 2019, 139 (08) :1047-1056
[10]   Galectin-3 Levels and Outcomes After Myocardial Infarction A Population-Based Study [J].
Asleh, Rabea ;
Enriquez-Sarano, Maurice ;
Jaffe, Allan S. ;
Manemann, Sheila M. ;
Weston, Susan A. ;
Jiang, Ruoxiang ;
Roger, Veronique L. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (18) :2286-2295